Our previous studies have shown that rapamycin suppresses IGF-1 stimulated motility in various tumor cell lines in part by inhibiting mTORC1-mediated 4E-BP1 and S6K1 pathways [23]. The gene discussed is EIF4EBP1; the disease is neoplasm.